Mode
Text Size
Log in / Sign up
N/A Completed N=17 Treatment

Treatment Parameters for the Empower Neuromodulation System (ENS)

Source: ClinicalTrials.gov NCT03807544 ↗
Enrolled (actual)
17
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcomePrimary: Number of Participants Who Experienced Effective Electrode Placement — 17; 17 Participants

Summary

The subject will be administered a treatment at a treatment location and then be asked if he/she believes it is the active treatment, sham treatment, or does not know. A clinical-grade nerve conduction assessment system will be used both to provide electrical stimulation at four locations to record peripheral responses. The subject will self-administer two treatment sessions at two active treatment sites.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Who Experienced Effective Electrode Placement
17; 17 —

Eligibility Criteria

Inclusion Criteria

  • Is 21-75 years old
  • Can provide informed consent
  • Currently has a stable living situation
  • Had one heavy drinking week (>7 drinks/week for women; >14 drinks/week for men) over the past 6 months
  • Has a breath alcohol concentration of 0.00% at enrollment
  • Is willing to follow all study procedures

Exclusion Criteria

  • Has been diagnosed with schizophrenia, epilepsy, peripheral neuropathy, or nerve damage
  • Has implanted electrical and/or neurostimulator device (e.g. pacemaker, defibrillator, vagal neurostimulator, deep brain stimulator, spinal stimulator, sacral stimulator, bone growth stimulator, or cochlear implant)
  • Has a tattoo or conductive, ferromagnetic, or other magnetic-sensitive metals that cannot be removed from the hand, wrist, or biceps
  • Is currently pregnant or breastfeeding
  • Has a bleeding disorder, a history of deep vein thrombosis, or is on anticoagulation drugs
  • Has used an investigational drug/device therapy within the past 4 weeks
  • Is deemed unsuitable for enrollment in study by the PI
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03807544). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search